Stuve O - Search Results

1

Bennett JL, O'Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von Büdingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C. Bennett JL, et al. Among authors: stuve o, o connor kc. Neurol Neuroimmunol Neuroinflamm. 2015 May 7;2(3):e104. doi: 10.1212/NXI.0000000000000104. eCollection 2015 Jun. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25977932 Free PMC article. Review.

2

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis.

Stüve O, Zamvil SS. Stüve O, et al. Curr Opin Neurol. 1999 Aug;12(4):395-401. doi: 10.1097/00019052-199908000-00005. Curr Opin Neurol. 1999. PMID: 10555827 Review.

3

Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).

Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS. Patarroyo JC, et al. Among authors: stuve o. Genes Immun. 2002 Feb;3(1):34-7. doi: 10.1038/sj.gene.6363808. Genes Immun. 2002. PMID: 11857059

4

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS. Youssef S, et al. Among authors: stuve o. Nature. 2002 Nov 7;420(6911):78-84. doi: 10.1038/nature01158. Nature. 2002. PMID: 12422218

5

The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.

Stüve O, Youssef S, Slavin AJ, King CL, Patarroyo JC, Hirschberg DL, Brickey WJ, Soos JM, Piskurich JF, Chapman HA, Zamvil SS. Stüve O, et al. J Immunol. 2002 Dec 15;169(12):6720-32. doi: 10.4049/jimmunol.169.12.6720. J Immunol. 2002. PMID: 12471103

6

Approved and future pharmacotherapy for multiple sclerosis.

Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS. Stüve O, et al. Neurologist. 2002 Sep;8(5):290-301. doi: 10.1097/00127893-200209000-00002. Neurologist. 2002. PMID: 12803676

7

Statins as potential therapeutic agents in neuroinflammatory disorders.

Stüve O, Youssef S, Steinman L, Zamvil SS. Stüve O, et al. Curr Opin Neurol. 2003 Jun;16(3):393-401. doi: 10.1097/01.wco.0000073942.19076.d1. Curr Opin Neurol. 2003. PMID: 12858078 Review.

8

Statins and their potential targets in multiple sclerosis therapy.

Stüve O, Prod'homme T, Slavin A, Youssef S, Dunn S, Steinman L, Zamvil SS. Stüve O, et al. Expert Opin Ther Targets. 2003 Oct;7(5):613-22. doi: 10.1517/14728222.7.5.613. Expert Opin Ther Targets. 2003. PMID: 14498824 Review.

9

The potential therapeutic role of statins in central nervous system autoimmune disorders.

Stüve O, Youssef S, Dunn S, Slavin AJ, Steinman L, Zamvil SS. Stüve O, et al. Cell Mol Life Sci. 2003 Nov;60(11):2483-91. doi: 10.1007/s00018-003-3146-0. Cell Mol Life Sci. 2003. PMID: 14625690 Review.

10

Statins as potential therapeutic agents in multiple sclerosis.

Stüve O, Prod'homme T, Youssef S, Dunn S, Neuhaus O, Weber M, Hartung HP, Steinman L, Zamvil SS. Stüve O, et al. Curr Neurol Neurosci Rep. 2004 May;4(3):237-44. doi: 10.1007/s11910-004-0044-2. Curr Neurol Neurosci Rep. 2004. PMID: 15102350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page